Hal V. Barron

Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors

Use And In-Hospital Mortality Associated With Two Cardiac Procedures, By Sex And Age: National Trends, 1990–2004

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Acute Coronary Care in the Elderly, Part I

Mortality Benefit of Immediate Revascularization of Acute ST-Segment Elevation Myocardial Infarction in Patients With Contraindications to Thrombolytic Therapy

Calcification of the Aortic Arch

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium

A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?

Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland

Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock

Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry

Severe Hypoglycemia and Risks of Vascular Events and Death

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

The Role of the Autonomic Nervous System in Sudden Cardiac Death

Eliminating Racial and Ethnic Disparities in Health Care: What Is the Role of Academic Medicine?

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

Azithromycin for the Secondary Prevention of Coronary Heart Disease Events

Bivalirudin during Primary PCI in Acute Myocardial Infarction

The Quality of Health Care Delivered to Adults in the United States

Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality

Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality and Outcomes

Macrophages in the Pathogenesis of Atherosclerosis

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry

Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction

Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999

Hemodynamic Effects of Intra-aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

Outpatient adherence to beta-blocker therapy after acute myocardial infarction

Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction

Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

The changing landscape of atherosclerosis

Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study

Prevalence, Clinical Characteristics, and Mortality Among Patients With Myocardial Infarction Presenting Without Chest Pain

Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction

A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Targeting the Chemokines in Cardiac Repair

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Severe Sepsis and Septic Shock

Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial

Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients With Preserved Left Ventricular Function

Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking

Nonresolving Inflammation

Short-term Prognosis After Emergency Department Diagnosis of TIA

Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges

Relation Between Hospital Primary Angioplasty Volume and Mortality for Patients With Acute MI Treated With Primary Angioplasty vs Thrombolytic Therapy

Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials

Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack

Systemic toll-like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction

Impact of Baseline Platelet Count in Patients Undergoing Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction (from the CADILLAC Trial)

The development of allergic inflammation

A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Adenosine as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction (AMISTAD-II)

Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade

Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)

Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction

The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis

The Next GME Accreditation System — Rationale and Benefits

Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no‐reflow phenomenon

Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: Insights from American Heart Association's Get With the Guidelines program

Guidelines for Percutaneous Coronary Interventions

Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction

Histological study on the distribution of autonomic nerves in the human heart

Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

Secondary prevention with folic acid: effects on clinical outcomes

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

Trends in Hospital Volume and Operative Mortality for High-Risk Surgery

Myocardial Reperfusion Injury

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

Autonomic nervous system control of the cardiovascular and respiratory systems in asthma

Symptoms in acute coronary syndromes: does sex make a difference?

Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction

Progress and challenges in translating the biology of atherosclerosis

The inflammatory response in myocardial injury, repair, and remodelling

Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events

Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns

Thirty-Year Trends (1975–2005) in the Magnitude, Patient Characteristics, and Hospital Outcomes of Patients With Acute Myocardial Infarction Complicated by Ventricular Fibrillation

Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies

Effect of Physician Volume on the Relationship Between Hospital Volume and Mortality During Primary Angioplasty

Inflammation, Atherosclerosis, and Coronary Artery Disease

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial

Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress

The Usage Patterns of Cardiac Bedside Markers Employing Point‐of‐Care Testing for Troponin in Non‐ST‐Segment Elevation Acute Coronary Syndrome: Results from CRUSADE

Shock in acute myocardial infarction: the Cape Horn for trials?

Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*

The inflammatory reflex

Women and Ischemic Heart Disease

Racial disparities in cancer therapy

Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry

The Percutaneous Ventricular Assist Device in Severe Refractory Cardiogenic Shock

Survival Advantage for Adult Hispanic Hemodialysis Patients? Findings from the End-Stage Renal Disease Clinical Performance Measures Project

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Heart failure after myocardial infarction: a review

Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial

Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study

The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study

Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome*

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Reperfusion therapy in elderly patients with acute myocardial infarction

Comparison of impact of emergency percutaneous revascularization on outcome of patients ≥75 to those <75 years of age with acute myocardial infarction complicated by cardiogenic shock

HIF-1α is required for development of the sympathetic nervous system

Cardiogenic Shock

Development of Monocytes, Macrophages, and Dendritic Cells

Myeloperoxidase-Generated Oxidants Modulate Left Ventricular Remodeling but Not Infarct Size After Myocardial Infarction

A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality

Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats

Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene

Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death

Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction

Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction

Cancer statistics, 2016

Targeting inflammatory pathways in myocardial infarction

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

E-Syts, a family of membranous Ca ²⁺ -sensor proteins with multiple C ₂ domains

The Biological Basis for Cardiac Repair After Myocardial Infarction

Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Relation Between Hospital Specialization With Primary Percutaneous Coronary Intervention and Clinical Outcomes in ST-Segment Elevation Myocardial Infarction

Cardiomyocyte-Specific Transforming Growth Factor β Suppression Blocks Neutrophil Infiltration, Augments Multiple Cytoprotective Cascades, and Reduces Early Mortality After Myocardial Infarction

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

Heart Rate Variability

Heart rate variability: Standards of measurement, physiological interpretation, and clinical use

Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Volume-Outcome Relation for Physicians and Hospitals Performing Angioplasty for Acute Myocardial Infarction in New York State

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

A comparison of the National Registry of Myocardial Infarction 2 with the Cooperative Cardiovascular Project

Early use of glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute myocardial infarction

Predictors of door-to-balloon delay in primary angioplasty

Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the national registry of myocardial infarction 2

Mode of onset of torsade de pointes in congenital long QT syndrome

Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator

The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age: findings from the cooperative cardiovascular project

Early use of ACE inhibitors in the treatment of acute myocardial infarction in the united states: experience from the National Registry of Myocardial Infarction 2

Sex and Racial Differences in the Management of Acute Myocardial Infarction, 1994 through 2002

Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain

Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator

Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (the second National Registry of Myocardial Infarction)

Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon

Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction

The Association between White Blood Cell Count and Acute Myocardial Infarction In‐hospital Mortality: Findings from the National Registry of Myocardial Infarction

β-Blocker Dosages and Mortality After Myocardial Infarction

Sex-Based Differences in Early Mortality after Myocardial Infarction

Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study

Autonomic nervous system and sudden cardiac death

Treatment and outcome of myocardial infarction in hospitals with and without invasive capability

The Volume of Primary Angioplasty Procedures and Survival after Acute Myocardial Infarction

The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2

Variation among Hospitals in Coronary-Angiography Practices and Outcomes after Myocardial Infarction in a Large Health Maintenance Organization

Use of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock

Disparities in the treatment of acute myocardial infarction: Underutilization of evidence-based therapies for patients with non-ST-segment myocardial infarction

Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States

Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction

Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Use of helicopter transportation in acute myocardial infarction in the United States

TIMI Myocardial Perfusion Grade and ST Segment Resolution: Association With Infarct Size as Assessed by Single Photon Emission Computed Tomography Imaging

Use of Emergency Medical Services in Acute Myocardial Infarction and Subsequent Quality of Care

Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction

Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction